載入...
Rituximab as first-line treatment for acquired thrombotic thrombocytopenic purpura
OBJECTIVE: To investigate the efficacy and safety of rituximab (RTX) as first-line treatment of acquired thrombotic thrombocytopenic purpura (aTTP). METHODS: Twenty-five patients with acute aTTP and/or severe a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13...
Na minha lista:
| 發表在: | J Int Med Res |
|---|---|
| Main Authors: | , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publications
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5536423/ https://ncbi.nlm.nih.gov/pubmed/28639502 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0300060517695646 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|